Epstein Secrets

so are the members of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of inside

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

so are the members of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of inside

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

so are the members of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of inside

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been